EC Number   |
Inhibitors |
Structure |
|---|
   1.14.99.22 | 1,4-anthraquinone |
about 20% residual activity at 10 mM |
   |
| 1.14.99.22 | 1,9-Dideoxyforskolin |
dose dependent inhibition |
|
| 1.14.99.22 | 1H-[1,2,4]oxadizolo[4,3-a]-quinoxalin-1-one |
a guanylate cyclase inhibitor, applied with ecdysone agonist RH-5849 results in 63% reduced E20M activity |
|
| 1.14.99.22 | 2-isopropoxy-1,4-naphthoquinone |
synthetic compound |
|
| 1.14.99.22 | 2-methoxy-1,4-anthraquinone |
about 18% residual activity at 1 mM |
|
| 1.14.99.22 | 2-methoxy-1,4-naphthoquinone |
isolated from the leaves of Impatiens glandulifera |
|
| 1.14.99.22 | 2-propoxy-1,4-naphthoquinone |
synthetic compound |
|
| 1.14.99.22 | 20-hydroxyecdysone |
competitive inhibition |
|
| 1.14.99.22 | 6-anilinoquinoline-5,6-quinone |
LY-38583, a guanylate cyclase inhibitor, applied with ecdysone agonist RH-5849 results in 80% reduced E20M activity, addition of guanylate cyclase activator S levels the activity to 78% of control activity |
|
| 1.14.99.22 | 7,8-Benzoflavone |
- |
|
